Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

ClinicalTrials.gov ID: NCT00483652

Public ClinicalTrials.gov record NCT00483652. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to show that individuals treated with Fampridine-SR tablets are significantly more likely to have consistent improvements in their walking than those treated with placebo tablets.

Study identification

NCT ID
NCT00483652
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Acorda Therapeutics
Industry
Enrollment
240 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2007 (Type not available)
Primary completion
Feb 2008 (Actual)
Completion
May 2008 (Actual)
Last update posted
Feb 4, 2016

2007 – 2008

United States locations

U.S. sites
36
U.S. states
24
U.S. cities
34
Facility City State ZIP Site status
Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center Phoenix Arizona 85013 —
HOPE Research Institute Phoenix Arizona 85050 —
Neurological Associates Fayetteville Arkansas 72703 —
Alta Bates Summit Medical Center - Research and Education Institute Berkeley California 94705 —
USC, Keck School of Medicine Health Care Consultation Center Los Angeles California 90033 —
UC Davis Sacramento California 95817 —
Yale University MS Center New Haven Connecticut 06510 —
Shepherd Center Atlanta Georgia 30309 —
Consultants in Neurology, Ltd. Northbrook Illinois 60062 —
Indiana University MS Center Indianapolis Indiana 46202 —
Associates in Neurology, PSC Lexington Kentucky 40503 —
Maryland Center for MS Baltimore Maryland 21201 —
Lahey Clinic Lexington Massachusetts 02421 —
The Schapiro Center for MS Golden Valley Minnesota 55422 —
Washington University School of Medicine St Louis Missouri 63110 —
Advanced Neurology Specialists Great Falls Montana 59405 —
UMDNJ Newark New Jersey 07103 —
Gimbel MS Center at Holy Name Hospital Teaneck New Jersey 07666 —
Jacobs Neurological Institute Buffalo General Hospital Buffalo New York 14203 —
Corinne Goldsmith Dickinson Center for MS New York New York 10029 —
Columbia University Multiple Sclerosis Clinical Care Center New York New York 10032 —
University of Rochester Rochester New York 14642 —
SUNY Stony Brook Stony Brook New York 11794 —
CMC - Neuroscience & Spine Institute, Division of Neurology Charlotte North Carolina 28207 —
Raleigh Neurology Associates Raleigh North Carolina 27607 —
Wake Forest University, Dept of Neurology, M.S. Research Winston-Salem North Carolina 27157 —
The Center for Neurological Services Bismarck North Dakota 58501 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Ohio State University MS Center Columbus Ohio 43221 —
Oregon Health & Science University, MS Center of Oregon, UHS-42 Portland Oregon 97239 —
Thomas Jefferson University Physicians Philadelphia Pennsylvania 19107 —
Neurological Research Center, Inc. Bennington Vermont 05201 —
Fletcher Allen Health Care Burlington Vermont 05401 —
MS Center at Evergreen Kirkland Washington 98034 —
CAMC Health Education & Research Institute Charleston West Virginia 25304 —
Center for Neurological Disorders of Aurora, St. Luke's Medical Center Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00483652, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2016 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00483652 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →